Category Health & IP

OMS: nouvelle réunion de négociation concernant la grippe H1N1 et l’échange des virus et audition devant le Conseil de l’Europe

Un accord prévoyant l’échange d’informations sur les virus et le partage des avantages liés à la gestion des droits de propriété intellectuelle qui en découlent devrait être conclu dans le cadre d’une nouvelle négociation intergouvernementale organisée sous les auspices de la directrice générale de l’Organisation mondiale de la Santé.

منظمة الصحة العالمية تحدد موعدا لعقد اجتماع جديد بشأن الأنفلونزا وتبادل الفيروسات بعد أن بدأت أوروبا في التحقيق في “هراء” هذه المنظمة

يُؤمل أن تُوضع اللمسات الأخيرة على اتفاق بشأن المواد المتعلقة بتبادل الفيروسات والفوائد وإدارة حقوق الملكية الفكرية المرتبطة بها من خلال دورة من المفاوضات الحكومية الدولية التي تيسّرها المديرة العامة لمنظمة الصحة العالمية.

Year Ahead: Biotech And Patentability Under Debate In The US, EU

Biotechnology lies at the intersection of a wide spectrum of fields, such as agriculture, health and environment. Because biotechnology relates to life sciences, it is often the subject of ethical, sometimes intense political debates between stakeholders, in particular involving intellectual property rights. In 2010, as the first signs of global economic recovery are emerging, the debates are expected to increase.

WHO Lashes Out As Council Of Europe Preps Hearing On Flu Pandemic

The World Health Organization today defended its declaration of a global influenza pandemic, and saying any allegations that it is fake are “wrong and irresponsible.” The statement comes as the Parliamentary Assembly of the Council of Europe (PACE) prepares for a public hearing tomorrow morning in Strasbourg to examine the allegations, involving representatives of the WHO and European vaccine manufacturers will be in attendance, as will independent medical experts.

Year Ahead: Range Of IP Policy Issues May See Action In United States In 2010

With the United States Congress attempting to wrap up healthcare – a move made more difficult after a Republican won a traditionally Democratic US Senate seat in January - issues such as tax increases for the nation’s largest financial institutions, energy reform and others may take centre stage. But that’s not to say there is not some room for intellectual property issues to be considered. Upcoming issues may include patent reform, biologic drugs, internet neutrality, enforcement, and performance rights.